Combination Chemo + IO Therapy in Advanced Non–Small Cell Lung Cancer
A comprehensive discussion on combination chemotherapy + immunotherapy regimens available to patients with advanced non–small cell lung cancer.
Source: onclive.com
Checkmate 227 News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Checkmate 227. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Checkmate 227 Today - Breaking & Trending Today
Dr Khalil on Benefits Derived From the POSEIDON Regimen in Metastatic NSCLC
Maya Khalil, MD, discusses the use of first-line durvalumab plus tremelimumab in patients with non–small cell lung cancer enrolled in the phase 3 POSEIDON trial, and sheds light on histologies and mutations that are associated with increased benefit with this regimen.
Source: onclive.com
Dr Khalil on the Use of Nivolumab/Ipilimumab Combination in NSCLC
Maya Khalil, MD, discusses key clinical trial updates on the use of nivolumab and ipilimumab with or without chemotherapy in non–small cell lung cancer.
Source: onclive.com